戻る Agenda
Session 7: Disease Awareness Campaigns - Best Practices and What to Avoid
Session Chair(s)
Nicol George, PHARMD, RPH
Vice President US Regulatory Affairs, Galderma, United States
Disease awareness campaigns are essential for informing healthcare professionals (HCPs) and patients. These campaigns highlight disease signs and symptoms, reduce stigma, and encourage proactive health management, enabling timely medical advice. For HCPs, they open dialogue with patients, promote health screenings, and share new insights, especially for rare diseases. This session explores best practices from pre-launch to post-launch, covering media, social channels, and HCP influencer safeguards, focusing on disease education without crossing into treatment promotion.
Learning Objective : - Discuss best practice recommendations to use disease awareness campaigns leading into anticipated drug approval
- Identify disease awareness education for HCPs and patients versus implied or expressed treatment claims to ensure compliance
- Analyze real-world examples of successful disease awareness HCP Influencer campaigns
Speaker(s)
Kevin Hollister, MBA, MPH, MS
Head of Advertising and Promotional Compliance, Alexion, United States
Disease Awareness Campaigns: A Regulatory Perspective
Adam Goodcoff, DO
Chief Medical Officer, HealthCentral, United States
Disease Awareness Campaigns Through an HCP Lens
Joshua Simon, MBA
SVP, Social Center of Excellence, CMI Media Group, United States
DSA in Social Media